EUVIMEDEUVIMED entdecken
Crossref

Design and Development of DNA Damage Chemical Inducers of Proximity for Targeted Cancer Therapy

Tian Qiu iD, Yeuan Ting Lee, Brendan G Dwyer iD, Yi Jer Tan, Ting Chen, Bryan A Romero, Yanlan Wang, Jiehui Deng, Tinghu Zhang iD, Gerald R Crabtree iD, Stephen M Hinshaw iD, Kwok-Kin Wong und 1 weitere

Journal of the American Chemical Society · 2026

DOI: 10.1021/jacs.5c17396 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2026. Verfasst von Tian Qiu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Systems Biology, ChEM-H and Stanford Cancer Institute, Stanford Medical School, Stanford University, Stanford, California …. Hauptthemen laut MEDLINE: DNA Damage, Antineoplastic Agents, Poly(ADP-ribose) Polymerase Inhibitors, Drug Design. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: NCI NIH HHS, National Cancer Institute, Lucile Packard Foundation for Children's Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Many chemotherapies are effective against cancers that display high levels of genome instability by disrupting or overwhelming the DNA damage response (DDR) to induce cell death. PARP inhibitors (PARPi) exploit this vulnerability by stalling DNA repair, particularly in homologous recombination-deficient cancer cells. Although PARPi are now used to treat BRCA1/2-mutated cancers such as ovarian and breast cancers, they are still limited to a narrow range of clinical indications and are susceptible to acquired resistance. Here, we introduce "DNA damage chemical inducers of proximity" (DD-CIPs), bivalent molecules that rewire the mechanism of action of conventional PARPi. The DD-CIPs function through chemically induced proximity between PARP1/2 and the chromatin remodeling protein, BRD4. From a candidate library of DD-CIPs, we identified DD-CIP1, which induces the DDR and apoptosis in cancer cells at two-digit nanomolar concentrations. Further optimization yielded DD-CIP2, which induces tumor cell death at nanomolar concentrations across diverse blood and solid cancer cells, including cancer types that are insensitive to PARPi. Using small-cell lung cancer (SCLC) as a model, we found that DD-CIP2 triggers DDR, cell cycle arrest, and apoptosis in vitro, leading to antitumor efficacy without substantial toxicity in preclinical SCLC xenograft models at well-tolerated doses. Our findings demonstrate that DD-CIPs may provide an opportunity to address the limitations of traditional PARPi and establish chemical-induced proximity as a strategy for modulating the DDR in cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA DamageAntineoplastic AgentsPoly(ADP-ribose) Polymerase InhibitorsDrug DesignNeoplasmsHumansAnimalsCell Line, TumorApoptosisMiceDrug Screening Assays, AntitumorCell Cycle ProteinsCell ProliferationMolecular StructureBromodomain Containing ProteinsTranscription Factors

Substanzen

Antineoplastic AgentsPoly(ADP-ribose) Polymerase InhibitorsCell Cycle ProteinsBRD4 protein, humanBromodomain Containing ProteinsTranscription Factors

Autor:innen und Institutionen

  • Department of Chemical and Systems Biology, ChEM-H and Stanford Cancer Institute, Stanford Medical School, Stanford University, Stanford, California 94305, United States.
  • Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, New York 10016, United States.
  • Department of Pathology, Stanford University, Stanford, California 94305, United States.
  • Department of Developmental Biology, Stanford University, Stanford, California 94305, United States.

ORCID-Profile: Tian Qiu, Brendan G Dwyer, Tinghu Zhang, Gerald R Crabtree, Stephen M Hinshaw, Nathanael S Gray

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • Lucile Packard Foundation for Children's Health
  • Victor Family Foundation
  • National Institutes of Health (NIH)
  • Spark Foundation

Zitieren

APA

Qiu, T., Lee, Y. T., Dwyer, B. G., Tan, Y. J., Chen, T., Romero, B. A., Wang, Y., Deng, J., Zhang, T., Crabtree, G. R., Hinshaw, S. M., Wong, K. K., & Gray, N. S. (2026). Design and Development of DNA Damage Chemical Inducers of Proximity for Targeted Cancer Therapy. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.5c17396

Vancouver

Qiu T, Lee YT, Dwyer BG, Tan YJ, Chen T, Romero BA, et al. Design and Development of DNA Damage Chemical Inducers of Proximity for Targeted Cancer Therapy. Journal of the American Chemical Society. 2026. doi:10.1021/jacs.5c17396

BibTeX
@article{Qiu2026,
  author = {Qiu, Tian and Lee, Yeuan Ting and Dwyer, Brendan G and Tan, Yi Jer and Chen, Ting and Romero, Bryan A and Wang, Yanlan and Deng, Jiehui and Zhang, Tinghu and Crabtree, Gerald R and Hinshaw, Stephen M and Wong, Kwok-Kin and Gray, Nathanael S},
  title = {Design and Development of DNA Damage Chemical Inducers of Proximity for Targeted Cancer Therapy},
  journal = {Journal of the American Chemical Society},
  year = {2026},
  doi = {10.1021/jacs.5c17396}
}
Kostenlos starten →